Rat Model Market Report 2024: Strategies And Recent Developments | Genoway S.A., Biomere, Transposagen Biopharmaceuticals Inc., Horizon Discovery Group PLC, Transviragen Inc

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2627

The Business Research Company offers in-depth market insights through Rat Model Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The rat model market size has grown strongly in recent years. It will grow from $1.56 billion in 2023 to $1.69 billion in 2024 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to rising demand for preclinical research, increasing government funding, research demand, drug development initiatives, rising chronic disease.

The rat model market size is expected to see strong growth in the next few years. It will grow to $2.34 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to expanding applications in personalized medicine, growing demand for animal models in drug discovery, increasing focus on disease prevention, expansion of biopharmaceutical industry, innovation in imaging techniques, government and private funding. Major trends in the forecast period include global collaborations in research, technological advancements in imaging, integration of omics technologies, advancements in genome editing techniques, growing importance of rat models in disease research, rise of personalized medicine and customized rat models.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=10100&type=smp

Market Segmentation:
The rat model market covered in this report is segmented -

1) By Type: Knockout, Outbred, Inbre*d, Hybrid, Immunodeficient, Conditioned
2) By Service: Cryopreservation, Breeding, Re-derivation, Genetic Testing, Quarantine Depending, Other Services
3) By Technology: Nuclear Transferase, Microinjection, Embryonic Stem Cell, Other Technologies
4) By Application: Oncology, Neurology, Immunology, Toxicology, Other Applications

Major Driver - Rising Chronic Disease Prevalence Ignites Growth In Rat Model Market Unveiling Insights For Therapeutic Development
The rising incidence of chronic diseases is expected to boost the growth of the rat model market going forward. Chronic diseases refer to conditions that last for a year or longer, hinder everyday activities, demand continuous medical care, or both. Rat models have been instrumental in studying the pathogenesis, immune responses, and treatment of chronic infections, providing valuable insights that can inform the development of new therapies and interventions. For instance, according to a report published by the National Institutes of Health (NIH), a US-based biomedical research agency, in 2023, in the United States, the number of people aged 50 and older with at least one chronic illness is predicted to rise by 99.5%, from 71.522 million in 2020 to 142.66 million in 2050. Additionally, the number of people with multimorbidity would rise by 91.16% from 7.8304 million in 2020 to 14.968 million in 2050. Therefore, the rising incidence of chronic diseases is driving the growth of the rat model market.

Competitive Landscape:
Major companies operating in the rat model market report are Genoway S.A., Biomere, Transposagen Biopharmaceuticals Inc., Horizon Discovery Group PLC, Transviragen Inc., Charles River Laboratories International Inc., Taconic Biosciences Inc., Envigo Ltd., Laboratory Corporation of America Holdings, Janvier Labs, Harlan Laboratories Inc., Sage Path Labs, Applied StemCell Inc., Regenera Pharma Ltd., Cyagen Biosciences Inc., Ozgene Pty Ltd, Yecuris Corporation, Hera BioLabs Inc., Beijing Biocytogen Co. Ltd., Ingenious Targeting Laboratory, InVivos Pte Ltd., Kymab Limited, Mirimus Inc., Pharmaron Beijing Co. Ltd., PolyGene AG, Shanghai Model Organisms Center Inc., Sino Biological Inc., Synthego Corporation, Transgenic Inc., ViGene Biosciences Inc., Viva Biotech Holdings, WuXi AppTec Co. Ltd.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/rat-model-global-market-report

Top Trend - Hera Biolabs And Charles River Laboratories Unite For Enhanced Oncology Research
Major companies operating in the rat model market are developing strategic partnerships for preclinical research in oncology and other therapeutic areas. Collaborating with the companies operating in the rat model enables them to focus on their core business while leveraging the efficiency and cost-effectiveness of these specialized providers, which have established infrastructure and resources for generating rat models. For instance, in March 2022, Hera BioLabs, a US-based biotechnology company partnered with Charles River Laboratories, International Inc., a US-based pharmaceutical company for the commercialization of Hera's SRG rat, also known as OncoRat. Under this collaboration, Charles River will breed, distribute, sell, and market the SRG rat directly to the preclinical research community. The SRG rat is a highly immunodeficient rat that is ideal for xenograft or PDX studies, providing unique advantages over mouse models for conducting in vivo efficacy evaluation of potential cancer therapies. The model overcomes the limitations of smaller mouse models, enabling larger tumor growth, easier surgeries, and more tissues and serum for analyses, including repeat sampling.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Rat Model Market Characteristics
3. Rat Model Market Trends And Strategies
4. Rat Model Market - Macro Economic Scenario
5. Rat Model Market Size And Growth
…..
27. Rat Model Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.